全文获取类型
收费全文 | 109888篇 |
免费 | 6153篇 |
国内免费 | 655篇 |
专业分类
耳鼻咽喉 | 1070篇 |
儿科学 | 3586篇 |
妇产科学 | 2516篇 |
基础医学 | 15780篇 |
口腔科学 | 4059篇 |
临床医学 | 9908篇 |
内科学 | 24644篇 |
皮肤病学 | 2734篇 |
神经病学 | 10712篇 |
特种医学 | 2562篇 |
外国民族医学 | 1篇 |
外科学 | 9821篇 |
综合类 | 402篇 |
一般理论 | 49篇 |
预防医学 | 10908篇 |
眼科学 | 1844篇 |
药学 | 7692篇 |
中国医学 | 452篇 |
肿瘤学 | 7956篇 |
出版年
2024年 | 124篇 |
2023年 | 1050篇 |
2022年 | 2250篇 |
2021年 | 3723篇 |
2020年 | 2351篇 |
2019年 | 3153篇 |
2018年 | 3580篇 |
2017年 | 2731篇 |
2016年 | 3166篇 |
2015年 | 3501篇 |
2014年 | 4603篇 |
2013年 | 6024篇 |
2012年 | 9158篇 |
2011年 | 9531篇 |
2010年 | 5200篇 |
2009年 | 4361篇 |
2008年 | 7554篇 |
2007年 | 7583篇 |
2006年 | 6991篇 |
2005年 | 6519篇 |
2004年 | 5863篇 |
2003年 | 5224篇 |
2002年 | 4694篇 |
2001年 | 554篇 |
2000年 | 395篇 |
1999年 | 614篇 |
1998年 | 805篇 |
1997年 | 659篇 |
1996年 | 559篇 |
1995年 | 465篇 |
1994年 | 442篇 |
1993年 | 359篇 |
1992年 | 296篇 |
1991年 | 196篇 |
1990年 | 204篇 |
1989年 | 183篇 |
1988年 | 174篇 |
1987年 | 148篇 |
1986年 | 163篇 |
1985年 | 114篇 |
1984年 | 141篇 |
1983年 | 135篇 |
1982年 | 159篇 |
1981年 | 121篇 |
1980年 | 125篇 |
1979年 | 74篇 |
1978年 | 79篇 |
1977年 | 72篇 |
1976年 | 59篇 |
1974年 | 53篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
991.
Hepatic apoptosis and proliferation in male and female rats fed alcohol: role of cytokines 总被引:7,自引:1,他引:7
Colantoni A Idilman R De Maria N La Paglia N Belmonte J Wezeman F Emanuele N Van Thiel DH Kovacs EJ Emanuele MA 《Alcoholism, clinical and experimental research》2003,27(7):1184-1189
Background: The female liver is more sensitive to the toxic effect of chronic alcohol intake than the male liver. The aim of the study was to compare the influence of gender and sex hormonal status on apoptosis and cell proliferation following chronic ethanol intake.
Methods: Male and female rats were pair fed for 8 weeks a liquid diet containing 36% of their total daily calories as ethanol (ETOH group) or sucrose (control group). Liver samples were analyzed for apoptosis and hepatocyte proliferation by immunohistochemistry. The hepatic production of factors able to influence cell death and proliferation, such as tumor necrosis factor alpha (TNFα) and interleukin 6 (IL-6) were determined.
Results: In both male and female rats, ethanol intake promoted apoptosis in the liver. This effect of ethanol was more evident in female than male rat livers. Hepatic TNFα levels, which promote apoptosis, are significantly more elevated in female than in male livers. Hepatic IL-6 production, which promotes hepatocyte proliferation, was induced by ethanol only in males, but not female animals.
Conclusion: This observed difference in cytokine responses may contribute to the enhanced sensitivity of female liver to EtOH-induced injury. 相似文献
Methods: Male and female rats were pair fed for 8 weeks a liquid diet containing 36% of their total daily calories as ethanol (ETOH group) or sucrose (control group). Liver samples were analyzed for apoptosis and hepatocyte proliferation by immunohistochemistry. The hepatic production of factors able to influence cell death and proliferation, such as tumor necrosis factor alpha (TNFα) and interleukin 6 (IL-6) were determined.
Results: In both male and female rats, ethanol intake promoted apoptosis in the liver. This effect of ethanol was more evident in female than male rat livers. Hepatic TNFα levels, which promote apoptosis, are significantly more elevated in female than in male livers. Hepatic IL-6 production, which promotes hepatocyte proliferation, was induced by ethanol only in males, but not female animals.
Conclusion: This observed difference in cytokine responses may contribute to the enhanced sensitivity of female liver to EtOH-induced injury. 相似文献
992.
993.
994.
Ghyslaine Bruna Djeunang Dongho Karthigayan Gunalan Mariangela LEpiscopia Giacomo Maria Paganotti Michela Menegon Rose Efeutmecheh Sangong Georges Bouting Mayaka Joseph Fondop Carlo Severini Martin Sanou Sobze Louis H. Miller Gianluca Russo 《The American journal of tropical medicine and hygiene》2021,104(3):987
995.
996.
José Alexandre da Rocha Curvelo Anna Lea Silva Barreto Camila A. dos Anjos Rafaela S. Santana Ariadne Nunes Alonso Maria Teresa Vilela Romanos Kelly C. G. de Moura Paula Fernandes Carneiro Maristela Barbosa Portela Maria do Carmo F. R. Pinto Rosangela Maria de Araújo Soares 《Medicinal chemistry research》2015,24(3):1155-1161
997.
998.
Ilias Karaiskos Maria Souli Helen Giamarellou 《Expert opinion on investigational drugs》2015,24(11):1501-1511
Introduction: Living in the ever-expanding era of multidrug-resistant (MDR), extensively drug-resistant (XDR), and even pandrug-resistant Gram-negative microorganisms, the medical community is facing the approaching fear of the “End of Antibiotics.” Plazomicin is a next-generation aminoglycoside designed to evade all clinically relevant aminoglycoside-modifying enzymes, the main mechanism of aminoglycoside resistance. A newer aminoglycoside active against several MDR-XDR microorganisms is herein presented and discussed.Areas covered: Herein, the authors present the currently available information on plazomicin. This includes the current knowledge concerning plazomicin’s: mechanisms of action, in vitro activity and interactions, its pharmacokinetics, its clinical efficacy in complicated urinary tract infections (cUTIs) and acute pyelonephritis, and its toxicity issues.Expert opinion: Plazomicin was developed to evade all clinically relevant aminoglycoside-modifying enzymes. Unfortunately, ribosomal enzymatic modification by ribosomal 16S-rRNA methyltransferases confers broad-spectrum high-level aminoglycoside resistance. Still, plazomicin demonstrates high activity against the Enterobacteriaceae including extended spectrum beta lactamase and most carbapenemase producers, as well as several of the non-fermenters. When compared to levofloxacin, the in vivo activity of plazomicin in complicated urinary tract infections (cUTIs) and in acute pyelonephritis in humans was very promising. Furthermore, regarding safety, no clinically significant effects on renal, vestibular, or cochlear function have been observed both at Phase I and II studies in humans, with mild to moderate adverse events being dose related. However, the authors believe that the real position of plazomicin in the MDR-XDR world will be revealed once pending Phase III studies are completed. 相似文献
999.
Luis M. Pérez-Belmonte MD PhD Jaime Sanz-Cánovas MD Mercedes Millán-Gómez MD PhD Julio Osuna-Sánchez MD Almudena López-Sampalo MD Michele Ricci MD Manuel Jiménez-Navarro MD PhD Maria D. López-Carmona MD PhD María Rosa Bernal-López PhD Miguel A. Barbancho MD PhD José P. Lara MD PhD Ricardo Gómez-Huelgas MD PhD 《Journal of the American Geriatrics Society》2022,70(3):862-871
1000.
Shira H. Fischer MD PhD Regina A. Shih PhD Tara L. McMullen PhD Maria O. Edelen PhD Sangeeta C. Ahluwalia PhD Emily K. Chen PhD Sarah E. Dalton MA Susan Paddock PhD Anthony Rodriguez PhD Debra Saliba MD MPH AGSF Stella Mandl BSW BSN RN Teresa Mota BSN RN Advisory Group on Medication Reconciliation in PAC 《Journal of the American Geriatrics Society》2022,70(4):1047-1056